CRT DISCOVERY LABORATORIES: Translating cutting edge science into innovative new therapies for cancer patients

View more

About Us

CRT Discovery Laboratories (CRT-DL) is the in-house drug discovery unit of Cancer Research Technology, the wholly-owned development and commercialisation arm of Cancer Research UK. Based at the Babraham Research Campus, Cambridge, and the London Bioscience Innovation Centre, CRT-DL comprises over 70 staff from both industrial and academic backgrounds.

More about us

Our Approach

We bring together the best minds in basic and clinical cancer research, the rigour and drive of pharmaceutical and biotech companies, and our in-house drug discovery and alliance management capabilities to deliver breakthrough medicines for cancer patients. In recent years, we have established successful alliances with AstraZeneca, Teva Pharmaceuticals and FORMA Therapeutics.

More about our approach

Our Science

Our laboratories house the personnel and equipment to progress projects from initial hypothesis through to proof of concept. We have an understanding of academic and industrial drivers, enabling us to build alliances that satisfy the curiosity of basic research and the rigour of drug discovery research.

More about our science

Our Partners